Blogposts over onze producten, onze samenwerkingen, ons nieuws,…
Effectiveness of using the REAtouch® during intensive and functional HABIT-ILE intervention for children with unilateral cerebral palsy
We are pleased to announce the publication of a randomised controlled trial evaluating the effectiveness of an intensive and functional HABIT-ILE (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities)
First clinical evaluation of the REAtouch® Home, for a personalised, functional and long-term neurorehabilitation at home.
The team of Professor Thierry LEJEUNE, medical practitioner from the physical medicine and rehabilitation department of the Cliniques universitaires Saint-Luc, has started the first clinical evaluation of the REAtouch® Home
De REAplan® 3.4 – Een nieuw ontwerp met verbeterde toegankelijkheid
Begin 2023 lanceert Axinesis de nieuwe versie van de REAplan®-robot. De REAplan® 3.4 heeft een verbeterd gebruiksgemak door een nieuw ontworpen onderstel en nieuwe softwarefuncties. Naar aanleiding van de feedback van
New Chief Medical Officer (CMO) started at Axinesis from the 1st of September !
Since the 1st of September, a new member has joined Axinesis. Maxime Gilliaux, physiotherapist, doctor in motor sciences and Executive MBA in health, is now our Chief Medical Officer. He
Proven effectiveness of early Robotic Assisted Therapy for upper limb rehabilitation after stroke
Study provides further evidence for the effectiveness of robot-assisted therapy in stroke upper limb rehabilitation Robot-assisted therapy (RAT) is of significant interest in early rehabilitation, when neuroplasticity is high but
De komst van REAtouch Lite® bij Axinesis
Axinesis breidt haar portfolio van intensieve functionele revalidatie uit Met trots presenteren wij de REAtouch® Lite: het apparaat voor gedecentraliseerde revalidatie van de bovenste ledematen in het revalidatiecentrum of thuis.